Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Austin

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Pediatrics|April 10, 2018
The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary HypertensionJohn P Kinsella, Robin H Steinhorn, Mary P Mullen, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Chest|October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosisD Hunter Best, Kelli L Sumner, Eric D Austin, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2018
FHIT, a Novel Modifier Gene in Pulmonary Arterial HypertensionSvenja Dannewitz Prosseda, Xuefei Tian, Kazuya Kuramoto, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
The European Respiratory Journal|June 18, 2021
Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet RegistrySteven H Abman, Mary P Mullen, Lynn A Sleeper, et al.
Chest|August 18, 2024
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk ModelsMegan Griffiths, Catherine E Simpson, Jun Yang, et al.
The European Respiratory Journal|February 8, 2020
Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertensionCatherine E Simpson, Jenny Y Chen, Rachel L Damico, et al.
Annals of the American Thoracic Society|January 20, 2022
Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary HypertensionErika B Rosenzweig, Angela Bates, Mary P Mullen, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Pediatrics|April 10, 2018
The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary HypertensionJohn P Kinsella, Robin H Steinhorn, Mary P Mullen, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Chest|October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosisD Hunter Best, Kelli L Sumner, Eric D Austin, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2018
FHIT, a Novel Modifier Gene in Pulmonary Arterial HypertensionSvenja Dannewitz Prosseda, Xuefei Tian, Kazuya Kuramoto, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
The European Respiratory Journal|June 18, 2021
Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet RegistrySteven H Abman, Mary P Mullen, Lynn A Sleeper, et al.
Chest|August 18, 2024
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk ModelsMegan Griffiths, Catherine E Simpson, Jun Yang, et al.
The European Respiratory Journal|February 8, 2020
Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertensionCatherine E Simpson, Jenny Y Chen, Rachel L Damico, et al.
Annals of the American Thoracic Society|January 20, 2022
Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary HypertensionErika B Rosenzweig, Angela Bates, Mary P Mullen, et al.
Pageof 18